Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multi-centre Trial of Alipogene Tiparvovec for the Treatment of LPLD Patients

NCT02904772 is registered in ClinicalTrials.gov with UniQure Biopharma B.V. as lead sponsor.

NCT NCT02904772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02904772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multi-centre Trial of Alipogene Tiparvovec for the Treatment of LPLD Patients
Lead sponsor
UniQure Biopharma B.V.
Phase
Phase 2
Overall status
Withdrawn
Start date
October 31, 2016
Completion date
September 30, 2020
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lpl deficiency